LONDON, Feb. 20, 2017 /PRNewswire/ -- Analyzes the worldwide markets for Peptic Ulcer Testing in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Download the full report: https://www.reportbuyer.com/product/4707091/
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 41 companies including many key and niche players such as:
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Biomerica, Inc.
- Biohit Oyj
- bioMérieux SA
Download the full report: https://www.reportbuyer.com/product/4707091/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW.............. II-1 Peptic Ulcer Disease - A Global Phenomenon II-1 H. Pylori Infection: The Root Cause of Peptic Ulcer Disease II-1 Table 1: Prevalence of H. Pylori Infection by Geographic Region - Prevalence Rate in % for Africa, Asia, Australasia, Eastern Europe, Latin America, North America and Western Europe.............. II-2 Diagnosis of Peptic Ulcer Disease - Testing for H. Pylori Infection.............. II-2 Table 2: Diagnosis of H. Pylori Infection - A Comparative Review of Sensitivity and Specificity of Various Tests II-3 Market Outlook.............. II-3 Developing Countries Lead Peptic Ulcer Testing Market II-4 Rising Incidence of Gastric Cancer: Potential Opportunities for H. Pylori Testing..............II-5 Table 3: Countries with Highest Prevalence of Stomach Cancer Worldwide - Ranked by Number of People with Stomach Cancer Per 100,000 Population (includes corresponding Graph/Chart) II-6 WHO Promotes H. Pylori Screening to Prevent Gastric Cancer- Related Deaths.............. II-7 Competitive Scenario..............II-8 Select H. Pylori Diagnostic Tests/Test Kits Available in the Market.............. II-8 A Review of Select H. Pylori Tests II-9 Heliprobe™ Systems..............II-9 QuickVue H. pylori gII test..............II-9 CLOtest Rapid Urease Test..............II-9 EZ-H.P. (Bulk) and EZ-H.P. (Professional) II-10 BreathID® Lab System..............II-10
2. MARKET TRENDS & ISSUES..............II-11 Sustained increase in Prevalence of Infectious Diseases Turns Focus onto Rapid Testing..............II-11 Higher Risk of H. pylori Disease Raises Demand for Testing from Elderly Population..............II-11 Table 4: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart) II-13
Table 5: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)..............II-14 Differential Accuracy of Diagnostic Tests in Adults and Children II-15 Rapid Tests - Enabling Faster Testing for H. Pylori Infection II-15 Rapid Urease Tests: Most Useful Invasive Test for H. Pylori Detection.............. II-15 Urea Breath Test - A Gold Standard in Non-Invasive Tests II-16 Availability of Tests Influences Market Adoption II-17 Cost Influencing Choice of Testing for H. Pylori II-17 Recommendations for H. Pylori Diagnostic Tests - An Overview II-17 Diagnostic Methods for H. Pylori Infection as Recommended by Guidelines in Select Countries II-18 Histology, UBT and SAT: Expensive Yet High-Value Offering Tests II-19 DVC-FISH Test Offers Positive Results in Detecting Viable H. Pylori Cells in Fecal Samples II-19 FIVH (fluorescence in vivo hybridization) - The New Kid on the Block.............. II-20 Guidelines for Diagnosing H. Pylori Ulcers in Children II-20 Antibody Tests Not Recommended for Children; Biopsy Tests More Pertinent.............. II-21
3. PEPTIC ULCERS - THE DISEASE, CAUSES, SYMPTOMS, TYPES, DIAGNOSIS, AND TREATMENT..............II-22 Peptic Ulcer - The Disease..............II-22 Discovery of Real Cause of Peptic Ulcers II-22 Causes of Peptic Ulcers..............II-22 Helicobacter Pylori (H. pylori) II-22 Non-steroidal Anti-inflammatory Drugs (NSAIDs) II-23 Others.............. II-23 Differential Diagnoses for Peptic Ulcer Disease II-24 Causes of Peptic Ulcers in Children II-24 Symptoms of Peptic Ulcers..............II-24 Types of Peptic Ulcers..............II-24 Gastric Ulcers.............. II-25 Duodenal Ulcers.............. II-25 The Diagnosis.............. II-25 Diagnosis of Ulcers..............II-25 Diagnosis of H. Pylori..............II-26 Treatment of Peptic Ulcers..............II-26 Drugs Prescribed in Peptic Ulcer Treatment II-27 Drugs Used in the Treatment of H. pylori Infection in Children II-27
4. PEPTIC ULCER DIAGNOSIS AND TESTS..............II-28 Diagnosis of Ulcers.............. II-28 The Upper GI Contrast Studies / Barium X-rays II-28 Endoscopy.............. II-28 Diagnosis of H. pylori..............II-28 A Comparison of Key Diagnosing Tests for H. pylori II-29 Tissue Tests.............. II-29 Gastrointestinal Endoscopy: Gold Standard in Diagnoses of Upper GI Diseases..............II-29 Rapid Urease Tests..............II-29 Histology Tests..............II-30 Gastritis Assessment..............II-30 Immunostaining Techniques..............II-30 Brush Cytology.............. II-30 Molecular Tests..............II-30 Culture Tests.............. II-31 Susceptibility Testing..............II-31 Blood Tests or Serological Tests II-31 Laboratory-based Tests..............II-32 ELISA Tests.............. II-32 Point-of-Care Tests..............II-32 Urea Breath Test - The Most Effective Diagnoses for H. Pylori Detection.............. II-32 Types of Urea Breath Tests..............II-33 Carbon-14-Urea Breath Test (PYtest) II-33 Precautionary Measures to be taken Prior to Performance of UBT II-33 Federal Legislation Governing the 14C UBT II-33 Carbon-13-Urea Breath Test..............II-33 Breath Tests Vs. Other Diagnostic Assays II-34 Stool Tests.............. II-34
5. PRODUCTS INNOVATIONS/INTRODUCTIONS II-35 Meridian Introduces Analyte Specific Reagent Product Range II-35 Kibion Rolls Out Kibion® Dynamic and extension device Kibion® Dynamic Pro.............. II-35 DiaSorin Introduces LIAISON Test for H. Pylori Outside US II-35 Biohit Oyj Introduces New BIOHIT GastroPanel Elisa Test Kits II-35
6. RECENT INDUSTRY ACTIVITY..............II-36 Mayloy Spindler Acquires Kibion..............II-36 Exalenz Receives FDA Approval for BreathID® Lab System II-36 Biohit Inks Distributor Agreement with Gulf Drug II-36 Biohit and Eurobio Ink Distribution Agreement II-36
7. FOCUS ON SELECT GLOBAL PLAYERS..............II-37 Becton, Dickinson and Company (US) II-37 Beckman Coulter, Inc. (US)..............II-37 Biomerica, Inc. (US)..............II-37 Biohit Oyj (Finland)..............II-38 bioMérieux SA (France)..............II-38 Bio-Rad Laboratories, Inc. (US)..............II-38 DiaSorin S.p.A. (Italy)..............II-39 EKF Diagnostics (UK)..............II-39 Exalenz Bioscience Ltd. (Israel) II-39 Halyard Health, Inc. (US)..............II-40 Kibion AB (Sweden)..............II-40 Meridian Bioscience, Inc. (US) II-40 Otsuka America Pharmaceutical, Inc. (US) II-41 Orion Diagnostica Oy (Finland) II-41 Polymedco CDP, LLC (US)..............II-41 Quidel Corporation (US)..............II-42 Sekisui Diagnostics, LLC (US)..............II-42 Thermo Fisher Scientific, Inc. (US) II-42
8. GLOBAL MARKET PERSPECTIVE..............II-43 Table 6: World Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) by Geographic Region - US, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. II-43
Table 7: World Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) by Geographic Region - US, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) II-44
Table 8: World 14-Year Perspective for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............II-45
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Market Overview.............. III-1 Age & Socioeconomic Status - Factors Contributing to Higher Incidences of H. Pylori Infection III-2 Table 9: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart) III-2 Competitive Scenario..............III-3 Reimbursement Codes..............III-3 Strategic Corporate Developments III-4 Key Players.............. III-4 B.Market Analytics..............III-8 Table 10: US Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-8
Table 11: US Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-9
2. JAPAN.............. III-10 Market Analysis.............. III-10 Table 12: Japanese Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-10
Table 13: Japanese Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-11
3. EUROPE.............. III-12 A.Market Analysis.............. III-12 Current and Future Analysis..............III-12 Product Innovations/Introductions III-12 Strategic Corporate Developments III-12 Key Players.............. III-13 B.Market Analytics..............III-15 Table 14: European Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-15
Table 15: European Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-16
4. ASIA-PACIFIC.............. III-17 A.Market Analysis.............. III-17 Current and Future Analysis..............III-17 India.............. III-17 B.Market Analytics..............III-18 Table 16: Asia-Pacific Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-18
Table 17: Asia-Pacific Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-19
5. LATIN AMERICA.............. III-20 Market Analysis.............. III-20 Table 18: Latin America Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-20
Table 19: Latin America Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-21
6. REST OF WORLD.............. III-22 A.Market Analysis.............. III-22 Current and Future Analysis..............III-22 Strategic Corporate Development III-22 Exalenz Bioscience Ltd. (Israel) - A Key Player III-22 B.Market Analytics..............III-23 Table 20: Rest of World Recent Past, Current & Future Analysis for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-23
Table 21: Rest of World Historic Review for Peptic Ulcer Testing (Rapid Microbiology Tests for H. Pylori) Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-24
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 41 (including Divisions/Subsidiaries - 46)
The United States (26) Canada (1) Europe (16) - France (3) - Germany (1) - The United Kingdom (3) - Italy (1) - Spain (1) - Rest of Europe (7) Asia-Pacific (Excluding Japan) (2) Middle East (1)
Download the full report: https://www.reportbuyer.com/product/4707091/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article